Lauren Merendino
Chief Commercial Officer · Day One Biopharmaceuticals, Inc.
- 2025
- Apr 23, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Lauren Merendino files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jeremy Bender - $321K in DAWN purchases and sales in the last 12 months
- Adam Dubow - $113K in DAWN purchases and sales in the last 12 months
- Charles N. York II - $107K in DAWN purchases and sales in the last 12 months
- Michael Vasconcelles - $32K in DAWN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Lauren Merendino?
Lauren Merendino is a corporate insider, tracked as Chief Commercial Officer of Day One Biopharmaceuticals, Inc. (DAWN). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Lauren Merendino last file a Form 4?
The most recent primary Form 4 on record is dated 23 April 2026, one of 6 filings going back to 2025.
Has Lauren Merendino been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($126K) across all tracked filings.
